Bluebird bio earnings call
WebMar 29, 2024 · Media Contacts. Jess Rowlands. Head of Corporate Communications (857) 299-6103. [email protected]. Investor Contacts. Courtney O’Leary. …
Bluebird bio earnings call
Did you know?
WebMar 29, 2024 · bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. ... - Management to host conference call today, March 29, 2024 at. Read more. 1/18/2024. bluebird bio, Inc. Announces Pricing of $120 Million … WebFeb 15, 2024 · Bluebird Bio (BLUE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024.
WebOct 28, 2024 · This estimate indicates a year-over-year change of -85.7%. Revenues for the quarter are expected to be $274.35 million, down 6.7% from the year-ago quarter.The consensus EPS estimate for Alkermes... WebApr 10, 2024 · bluebird bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Operational Progress finance.yahoo.com - March 29 at 9:02 AM: Research Analysts Set Expectations for bluebird bio, Inc.'s FY2024 Earnings (NASDAQ:BLUE) americanbankingnews.com - March 29 at 1:24 AM: bluebird bio Earnings Preview …
WebMay 3, 2024 · Bluebird Bio (BLUE Quick Quote BLUE - Free Report) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. This ... WebApr 10, 2024 · BLUE Options Chain bluebird bio Put and Call Options Lowest-Rated Stocks NASDAQ:BLUE bluebird bio - BLUE Options Chain & Prices $2.95 -0.15 (-4.84%) (As of 04/10/2024 12:28 PM ET) Compare Today's Range $2.92 $3.08 50-Day Range $3.07 $6.69 52-Week Range $2.87 $8.58 Volume 1.81 million shs Average Volume 4.22 million …
Web1 day ago · Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. The company’s stock has a 52-week low of $2.78. RSI Value: 29.91 BLUE Price...
WebApr 11, 2024 · bluebird bio, Inc. is a biotechnology company. The Company is principally focused on researching, developing and commercializing gene therapies for genetic diseases. The Company’s gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for sickle cell disease … hublot shopeeWebAug 9, 2024 · Bluebird Bio, Inc. (NASDAQ:NASDAQ:BLUE) Q2 2024 Earnings Conference Call August 9, 2024 8:00 AM ETCompany ParticipantsNick Leschly – Chief … hohlflexWebAug 5, 2024 · bluebird bio is a trademark of bluebird bio, Inc. Contacts Investors & Media Investors: Elizabeth Pingpank, 617-914-8736 [email protected] Media: Jenn Snyder, 617-448-0281... hublot shawn carterWebThe average Bluebird Bio salary ranges from approximately $56,000 per year for Operations Associate to $210,828 per year for Pharmacologist. Average Bluebird Bio … hublot showroomWebAug 9, 2024 · [email protected] Investor Contacts Courtney O’Leary Investor Relations (978) 621-7347 [email protected] Event Details bluebird bio Second Quarter 2024 Earnings Conference Call Aug 9, 2024 at 8:00 AM EDT Webcast Presentation Click here for webcast Supporting Materials hublot service usaWebbluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements ... hublot service watchWebAug 5, 2024 · bluebird bio, Inc. (NASDAQ: BLUE) today announced that the Company will report financial results for the second quarter ended June 30, 2024 on Monday, August … hublot second hand